跳转到主内容

非常抱歉,我们不完全支持您的浏览器。如果您可以选择,请升级到较新版本或使用 Mozilla Firefox、Microsoft Edge、Google Chrome 或 Safari 14 或更高版本。如果您无法进行此操作且需要支持,请将您的反馈发送给我们。

全新设计的官网为您带来全新体验,期待您的反馈 在新的选项卡/窗口中打开

Elsevier
通过我们出版

Terms and Conditions for use of Elsevier content in PubMed Central (PMC)

Gold open access 

Gold open access articles from Elsevier journals (where a fee has been paid by the author) are all immediately free to read and access on ScienceDirect. In addition to the article appearing on ScienceDirect, Elsevier in some cases (e.g., where we have a gold OA deposit agreement with a funding body) sends to PubMedCentral (PMC) the final authoritative version of the published article and authorizes its public posting on PMC immediately, and this site will also link directly to the journal article on Elsevier’s websites.

The user license that appears on the individual article (as selected by the author) will set out the terms on which you can use these — learn more about those user terms. If you want to use the article in a way that is not covered by the relevant user license, please find out how to obtain permission.

Green open access

As a service to our authors, Elsevier deposits to PMC author manuscripts on behalf of Elsevier authors reporting NIH-funded research. Elsevier sends to PMC the final peer-reviewed manuscript, which was accepted for publication and sent to Elsevier's production department, and that reflects any author-agreed changes made in response to peer-review comments. Elsevier authorizes the author manuscript's public access posting 12 months after final publication.

The user license that applies to these author manuscripts is the Creative Commons Attribution Non-Commercial No-Derivatives license (CC BY NC ND) — learn more about this user license. If you want to use the content in a way that is not covered by this user license, please find out how to obtain permission.

Please note: individual modifications to these general policies may apply to some Elsevier journals and society publishing partners.